Importantly, lipid metabolism is dramatically altered in RTT patients and Mecp2 KO mouse models (Buchovecky et al, 2013; Golubiani et al, 2021; Kyle et al, 2016, 2018). This evidence concerns the gene MECP2 and Rett syndrome.